Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
239 SEK | 0.00% | +2.58% | +12.74% |
Feb. 07 | Transcript : CellaVision AB, Q4 2023 Earnings Call, Feb 07, 2024 | |
Feb. 07 | CellaVision AB Proposes Dividend for the Year 2023 | CI |
Sales 2023 | 677M 63.28M | Sales 2024 * | 782M 73.01M | Capitalization | 5.7B 533M |
---|---|---|---|---|---|
Net income 2023 | 130M 12.15M | Net income 2024 * | 174M 16.26M | EV / Sales 2023 | 7.38 x |
Net cash position 2023 | 56.94M 5.32M | Net cash position 2024 * | 117M 10.9M | EV / Sales 2024 * | 7.14 x |
P/E ratio 2023 |
38.8
x | P/E ratio 2024 * |
32.8
x | Employees | - |
Yield 2023 |
1.06% | Yield 2024 * |
1.04% | Free-Float | 61.96% |
Latest transcript on CellaVision AB
1 week | +2.58% | ||
Current month | -2.85% | ||
1 month | -2.65% | ||
3 months | +13.81% | ||
6 months | +49.94% | ||
Current year | +12.74% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 239 | 0.00% | 1,866 |
24-03-27 | 239 | +1.06% | 14,762 |
24-03-26 | 236.5 | +6.05% | 12,612 |
24-03-25 | 223 | +2.29% | 18,654 |
24-03-22 | 218 | -6.44% | 24,821 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.74% | 534M | |
-34.95% | 3.2B | |
+12.43% | 1.78B | |
-0.43% | 1.66B | |
+36.05% | 1.37B | |
-3.90% | 1.11B | |
-19.15% | 927M | |
-6.11% | 732M | |
-11.71% | 735M | |
-.--% | 307M |